CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-19 | Bowden Christopher Chief Medical Officer | Shares withheld for taxes | −818 | $58.03 | $47K | 7,195 |
| 2019-02-19 | Biller Scott Chief Scientific Officer | Shares withheld for taxes | −876 | $58.03 | $51K | 26,511 |
| 2019-02-19 | Alenson Carman Principal Accounting Officer | Shares withheld for taxes | −278 | $58.03 | $16K | 512 |
| 2019-02-16 | Schenkein David P Director | Option exercise | +8,125 | 91,974 | ||
| 2019-02-16 | Schenkein David P Director | Option exercise · Restricted stock units | −8,125 | 16,250 | ||
| 2019-02-16 | Hoerter Steven L. Chief Commercial Officer | Option exercise | +2,750 | 11,981 | ||
| 2019-02-16 | Hoerter Steven L. Chief Commercial Officer | Option exercise · Restricted stock units | −2,750 | 5,500 | ||
| 2019-02-16 | Hirsch Andrew Chief Financial Officer | Option exercise | +2,750 | 13,195 | ||
| 2019-02-16 | Hirsch Andrew Chief Financial Officer | Option exercise · Restricted stock units | −2,750 | 5,500 | ||
| 2019-02-16 | Bowden Christopher Chief Medical Officer | Option exercise | +2,750 | 8,013 | ||
| 2019-02-16 | Bowden Christopher Chief Medical Officer | Option exercise · Restricted stock unit | −2,750 | 5,500 | ||
| 2019-02-16 | Biller Scott Chief Scientific Officer | Option exercise | +2,750 | 27,387 | ||
| 2019-02-16 | Biller Scott Chief Scientific Officer | Option exercise · Restricted stock units | −2,750 | 5,500 | ||
| 2019-02-16 | Alenson Carman Principal Accounting Officer | Option exercise | +790 | 790 | ||
| 2019-02-16 | Alenson Carman Principal Accounting Officer | Option exercise · Restricted stock units | −790 | 1,580 | ||
| 2019-02-01 | FOUSE JACQUALYN A Chief Executive Officer | Grant or award · Stock option (right to buy) | +350,346 | 350,346 | ||
| 2019-02-01 | FOUSE JACQUALYN A Chief Executive Officer | Grant or award · Performance share units | +42,695 | 42,695 | ||
| 2019-01-22 | Hirsch Andrew Chief Financial Officer | Shares withheld for taxes | −4,555 | $52.82 | $241K | 10,445 |
| 2019-01-22 | Hoerter Steven L. Chief Commercial Officer | Shares withheld for taxes | −5,769 | $52.82 | $305K | 9,231 |
| 2019-01-22 | Bowden Christopher Chief Medical Officer | Shares withheld for taxes | −1,960 | $52.82 | $104K | 5,229 |
Page 55 of 63 · 1,252 trades